ANGIODYNAMICS INC — Director's Dealing 2017

Jun 2, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2017-04-26

Reporting Person: Richard Stark (SVP, GM - Oncology)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	647	Direct
Common Stock	3436	Direct
Common Stock	4287	Direct
Common Stock	4718	Direct
Common Stock	5345	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$16.59	2023-07-27	Common Stock (12102)		Direct
Non-Qualified Stock Option (right to buy)	$15.95	2022-07-22	Common Stock (14704)		Direct
Non-Qualified Stock Option (right to buy)	$14.07	2021-07-25	Common Stock (13575)		Direct
Non-Qualified Stock Option (right to buy)	$11.92	2020-08-06	Common Stock (17409)		Direct
Non-Qualified Stock Option (right to buy)	$10.63	2019-08-17	Common Stock (10000)		Direct
Performance Right	$		Common Stock (6872)		Direct
Performance Right	$		Common Stock (5716)		Direct
Performance Right	$		Common Stock (6291)		Direct

Footnotes

F1: This grant of 3,436 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 3,436 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 27, 2017, such that 25% of the restricted stock units will vest on each of July 27, 2017, 2018, 2019 and 2020.

F2: This grant of 4,287 shares of Common Stock, represents 4,287 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 22, 2016, such that 25% of the restricted stock units vested on July 22, 2016 and 25% of the restricted stock units will vest on each of July 22, 2017, 2018 and 2019. 3,216 restricted stock units remain unvested.

F3: This grant of 4,718 shares of Common Stock, represents 4,718 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 25, 2015, such that 25% of the restricted stock units vested on July 25, 2015 and July 25, 2016 and 25% of the restricted stock units will vest on July 25, 2017 and July 25, 2018. 2,360 restricted stock units remain unvested.

F4: This grant of 5,345 shares of Common Stock, represents 5,345 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on August 6, 2014, such that 25% of the restricted stock units vested on August 6, 2014, August 6, 2015 and August 6, 2016 and 25% of the restricted stock units will vest on August 6, 2017. 1,337 restricted stock units remain unvested.

F5: These stock options vest in four equal annual installments beginning on July 27, 2017, such that 25% of the options will vest on each of July 27, 2017, 2018, 2019 and 2020.

F6: These stock options vest in four equal annual installments beginning on July 22, 2016, such that 25% of the options vested on July 22, 2016 and 25% of the options will vest on each of July 22, 2017, 2018 and 2019.

F7: These stock options vest in four equal annual installments beginning on July 25, 2015, such that 25% of the options vested on July 25, 2015 and July 25, 2016 and 25% of the options will vest on July 25, 2017 and July 25, 2018.

F8: These stock options vest in four equal annual installments beginning on August 6, 2014, such that 25% of the options vested on August 6, 2014, August 6, 2015 and August 6, 2016 and 25% of the options will vest on August 6, 2017.

F9: These stock options vest in four equal annual installments beginning on August 17, 2013, such that 25% of the options vested on each of August 17, 2013, 2014, 2015 and 2016.

F10: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2017, 2018 and 2019. Any shares that do not vest at the end of the performance period will be forfeited.

F11: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2016, 2017 and 2018. Any shares that do not vest at the end of the performance period will be forfeited.

F12: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2015, 2016 and 2017. Any shares that do not vest at the end of the performance period will be forfeited.